Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYTM | JANX | VCEL | ||
| Company | Rhythm Pharmaceuticals Inc | Janux Therapeutics Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.60 | 47.85 | 46.44 | ||
| High | 39.37 | 61.00 | 47.15 | ||
| Low | 38.19 | 47.58 | 46.21 | ||
| Last | 38.82 | 56.08 | 46.67 | ||
| Change | +0.54 | +8.69 | +0.62 | ||
| % Change | +1.41% | +18.34% | +1.35% | ||
| Volume | 280,200 | 1,536,500 | 248,800 | ||
| 20-Day Average Volume | 474,740 | 915,445 | 332,010 | ||
| Previous Close | 38.28 | 47.39 | 46.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.91 | 45.70 | 47.83 | ||
| 20-Day Raw Stochastic | 28.11% | 81.34% | 42.42% | ||
| 20-Day Relative Strength | 45.08% | 71.38% | 49.49% | ||
| Weighted Alpha | +70.91 | -11.16 | +44.55 | ||
| Today's Opinion | 8% Sell | 100% Buy | 56% Buy | ||
| Previous Opinion | 8% Sell | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 04/22/24 | +14.73% since 04/22/24 | +2.84% since 04/22/24 | ||
| Low | 37.36 on 04/26/24 | 45.68 on 04/25/24 | 44.50 on 04/25/24 | ||
| High | 41.85 on 04/23/24 | 61.00 on 04/29/24 | 47.15 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -10.41% since 03/28/24 | +48.95% since 03/28/24 | -10.28% since 03/28/24 | ||
| Low | 36.92 on 04/19/24 | 34.63 on 04/05/24 | 42.38 on 04/19/24 | ||
| High | 43.68 on 04/09/24 | 61.00 on 04/29/24 | 53.05 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -13.68% since 01/29/24 | +489.08% since 01/29/24 | +4.74% since 01/29/24 | ||
| Low | 36.92 on 04/19/24 | 7.79 on 02/05/24 | 41.58 on 02/07/24 | ||
| High | 52.57 on 02/12/24 | 61.00 on 04/29/24 | 53.05 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +76.45% since 10/27/23 | +831.56% since 10/27/23 | +42.20% since 10/27/23 | ||
| Low | 21.67 on 10/30/23 | 5.65 on 11/10/23 | 32.28 on 11/09/23 | ||
| High | 52.57 on 02/12/24 | 61.00 on 04/29/24 | 53.05 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,302,159 | 2,448,167 | 2,227,899 | ||
| Shares Outstanding, K | 60,140 | 51,660 | 48,380 | ||
| Annual Sales | 77,430,000 | 8,080,000 | 197,520,000 | ||
| Annual Net Income | -184,680,000 | -58,290,000 | -3,180,000 | ||
| Last Quarter Sales | 24,230,000 | 2,460,000 | 65,000,000 | ||
| Last Quarter Net Income | -41,630,000 | -11,760,000 | 12,990,000 | ||
| 60-Month Beta | 1.90 | 4.18 | 1.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.70 on 02/22/24 | -0.25 on 03/08/24 | 0.26 on 02/29/24 | ||
| Latest Earnings Date | 05/07/24 | 05/14/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||